 | • レポートコード：QY2207C3788 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（納期：3日） • 産業分類：新技術 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界の新型コロナウイルス感染症治療薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に新型コロナウイルス感染症治療薬の世界市場のxxx％を占める「経口」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「軽度-中等度新型コロナウイルス感染症」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の新型コロナウイルス感染症治療薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの新型コロナウイルス感染症治療薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの新型コロナウイルス感染症治療薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 新型コロナウイルス感染症治療薬のグローバル主要メーカーには、Pfizer (Paxlovid)、VEKLURY (Remdesivir)、Lagevrio、GSK (Sotrovimab)、Regeneron (Ronapreve)、Yiling Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 新型コロナウイルス感染症治療薬市場は、種類と用途によって区分されます。世界の新型コロナウイルス感染症治療薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 経口、注射 【用途別セグメント】 軽度-中等度新型コロナウイルス感染症、重症患者 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 新型コロナウイルス感染症治療薬製品概要 - 種類別市場（経口、注射） - 用途別市場（軽度-中等度新型コロナウイルス感染症、重症患者） - 調査の目的 ・エグゼクティブサマリー - 世界の新型コロナウイルス感染症治療薬販売量予測2017-2028 - 世界の新型コロナウイルス感染症治療薬売上予測2017-2028 - 新型コロナウイルス感染症治療薬の地域別販売量 - 新型コロナウイルス感染症治療薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別新型コロナウイルス感染症治療薬販売量 - 主要メーカー別新型コロナウイルス感染症治療薬売上 - 主要メーカー別新型コロナウイルス感染症治療薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（経口、注射） - 新型コロナウイルス感染症治療薬の種類別販売量 - 新型コロナウイルス感染症治療薬の種類別売上 - 新型コロナウイルス感染症治療薬の種類別価格 ・用途別市場規模（軽度-中等度新型コロナウイルス感染症、重症患者） - 新型コロナウイルス感染症治療薬の用途別販売量 - 新型コロナウイルス感染症治療薬の用途別売上 - 新型コロナウイルス感染症治療薬の用途別価格 ・北米市場 - 北米の新型コロナウイルス感染症治療薬市場規模（種類別、用途別） - 主要国別の新型コロナウイルス感染症治療薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの新型コロナウイルス感染症治療薬市場規模（種類別、用途別） - 主要国別の新型コロナウイルス感染症治療薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の新型コロナウイルス感染症治療薬市場規模（種類別、用途別） - 主要国別の新型コロナウイルス感染症治療薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の新型コロナウイルス感染症治療薬市場規模（種類別、用途別） - 主要国別の新型コロナウイルス感染症治療薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの新型コロナウイルス感染症治療薬市場規模（種類別、用途別） - 主要国別の新型コロナウイルス感染症治療薬市場規模（トルコ、サウジアラビア） ・企業情報 Pfizer (Paxlovid)、VEKLURY (Remdesivir)、Lagevrio、GSK (Sotrovimab)、Regeneron (Ronapreve)、Yiling Pharmaceutical ・産業チェーン及び販売チャネル分析 - 新型コロナウイルス感染症治療薬の産業チェーン分析 - 新型コロナウイルス感染症治療薬の原材料 - 新型コロナウイルス感染症治療薬の生産プロセス - 新型コロナウイルス感染症治療薬の販売及びマーケティング - 新型コロナウイルス感染症治療薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 新型コロナウイルス感染症治療薬の産業動向 - 新型コロナウイルス感染症治療薬のマーケットドライバー - 新型コロナウイルス感染症治療薬の課題 - 新型コロナウイルス感染症治療薬の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Covid-19 Treatment Medicine Market
Due to the COVID-19 pandemic, the global Covid-19 Treatment Medicine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Oral accounting for % of the Covid-19 Treatment Medicine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Mild-to-Moderate COVID-19 segment is altered to an % CAGR throughout this forecast period.
China Covid-19 Treatment Medicine market size is valued at US$ million in 2021, while the US and Europe Covid-19 Treatment Medicine are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Covid-19 Treatment Medicine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Covid-19 Treatment Medicine include Pfizer (Paxlovid), VEKLURY (Remdesivir), Lagevrio, GSK (Sotrovimab), Regeneron (Ronapreve) and Yiling Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Covid-19 Treatment Medicine Scope and Segment
Covid-19 Treatment Medicine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Covid-19 Treatment Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Oral
Injetion
Segment by Application
Mild-to-Moderate COVID-19
Severe Patient
By Company
Pfizer (Paxlovid)
VEKLURY (Remdesivir)
Lagevrio
GSK (Sotrovimab)
Regeneron (Ronapreve)
Yiling Pharmaceutical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Covid-19 Treatment Medicine Product Introduction
1.2 Market by Type
1.2.1 Global Covid-19 Treatment Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Injetion
1.3 Market by Application
1.3.1 Global Covid-19 Treatment Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Mild-to-Moderate COVID-19
1.3.3 Severe Patient
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Covid-19 Treatment Medicine Sales Estimates and Forecasts 2017-2028
2.2 Global Covid-19 Treatment Medicine Revenue Estimates and Forecasts 2017-2028
2.3 Global Covid-19 Treatment Medicine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Covid-19 Treatment Medicine Sales by Region
2.4.1 Global Covid-19 Treatment Medicine Sales by Region (2017-2022)
2.4.2 Global Sales Covid-19 Treatment Medicine by Region (2023-2028)
2.5 Global Covid-19 Treatment Medicine Revenue by Region
2.5.1 Global Covid-19 Treatment Medicine Revenue by Region (2017-2022)
2.5.2 Global Covid-19 Treatment Medicine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Covid-19 Treatment Medicine Sales by Manufacturers
3.1.1 Global Top Covid-19 Treatment Medicine Manufacturers by Sales (2017-2022)
3.1.2 Global Covid-19 Treatment Medicine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Covid-19 Treatment Medicine in 2021
3.2 Global Covid-19 Treatment Medicine Revenue by Manufacturers
3.2.1 Global Covid-19 Treatment Medicine Revenue by Manufacturers (2017-2022)
3.2.2 Global Covid-19 Treatment Medicine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Covid-19 Treatment Medicine Revenue in 2021
3.3 Global Covid-19 Treatment Medicine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Covid-19 Treatment Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Covid-19 Treatment Medicine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Covid-19 Treatment Medicine Sales by Type
4.1.1 Global Covid-19 Treatment Medicine Historical Sales by Type (2017-2022)
4.1.2 Global Covid-19 Treatment Medicine Forecasted Sales by Type (2023-2028)
4.1.3 Global Covid-19 Treatment Medicine Sales Market Share by Type (2017-2028)
4.2 Global Covid-19 Treatment Medicine Revenue by Type
4.2.1 Global Covid-19 Treatment Medicine Historical Revenue by Type (2017-2022)
4.2.2 Global Covid-19 Treatment Medicine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Covid-19 Treatment Medicine Revenue Market Share by Type (2017-2028)
4.3 Global Covid-19 Treatment Medicine Price by Type
4.3.1 Global Covid-19 Treatment Medicine Price by Type (2017-2022)
4.3.2 Global Covid-19 Treatment Medicine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Covid-19 Treatment Medicine Sales by Application
5.1.1 Global Covid-19 Treatment Medicine Historical Sales by Application (2017-2022)
5.1.2 Global Covid-19 Treatment Medicine Forecasted Sales by Application (2023-2028)
5.1.3 Global Covid-19 Treatment Medicine Sales Market Share by Application (2017-2028)
5.2 Global Covid-19 Treatment Medicine Revenue by Application
5.2.1 Global Covid-19 Treatment Medicine Historical Revenue by Application (2017-2022)
5.2.2 Global Covid-19 Treatment Medicine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Covid-19 Treatment Medicine Revenue Market Share by Application (2017-2028)
5.3 Global Covid-19 Treatment Medicine Price by Application
5.3.1 Global Covid-19 Treatment Medicine Price by Application (2017-2022)
5.3.2 Global Covid-19 Treatment Medicine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Covid-19 Treatment Medicine Market Size by Type
6.1.1 North America Covid-19 Treatment Medicine Sales by Type (2017-2028)
6.1.2 North America Covid-19 Treatment Medicine Revenue by Type (2017-2028)
6.2 North America Covid-19 Treatment Medicine Market Size by Application
6.2.1 North America Covid-19 Treatment Medicine Sales by Application (2017-2028)
6.2.2 North America Covid-19 Treatment Medicine Revenue by Application (2017-2028)
6.3 North America Covid-19 Treatment Medicine Market Size by Country
6.3.1 North America Covid-19 Treatment Medicine Sales by Country (2017-2028)
6.3.2 North America Covid-19 Treatment Medicine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Covid-19 Treatment Medicine Market Size by Type
7.1.1 Europe Covid-19 Treatment Medicine Sales by Type (2017-2028)
7.1.2 Europe Covid-19 Treatment Medicine Revenue by Type (2017-2028)
7.2 Europe Covid-19 Treatment Medicine Market Size by Application
7.2.1 Europe Covid-19 Treatment Medicine Sales by Application (2017-2028)
7.2.2 Europe Covid-19 Treatment Medicine Revenue by Application (2017-2028)
7.3 Europe Covid-19 Treatment Medicine Market Size by Country
7.3.1 Europe Covid-19 Treatment Medicine Sales by Country (2017-2028)
7.3.2 Europe Covid-19 Treatment Medicine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Covid-19 Treatment Medicine Market Size by Type
8.1.1 Asia Pacific Covid-19 Treatment Medicine Sales by Type (2017-2028)
8.1.2 Asia Pacific Covid-19 Treatment Medicine Revenue by Type (2017-2028)
8.2 Asia Pacific Covid-19 Treatment Medicine Market Size by Application
8.2.1 Asia Pacific Covid-19 Treatment Medicine Sales by Application (2017-2028)
8.2.2 Asia Pacific Covid-19 Treatment Medicine Revenue by Application (2017-2028)
8.3 Asia Pacific Covid-19 Treatment Medicine Market Size by Region
8.3.1 Asia Pacific Covid-19 Treatment Medicine Sales by Region (2017-2028)
8.3.2 Asia Pacific Covid-19 Treatment Medicine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Covid-19 Treatment Medicine Market Size by Type
9.1.1 Latin America Covid-19 Treatment Medicine Sales by Type (2017-2028)
9.1.2 Latin America Covid-19 Treatment Medicine Revenue by Type (2017-2028)
9.2 Latin America Covid-19 Treatment Medicine Market Size by Application
9.2.1 Latin America Covid-19 Treatment Medicine Sales by Application (2017-2028)
9.2.2 Latin America Covid-19 Treatment Medicine Revenue by Application (2017-2028)
9.3 Latin America Covid-19 Treatment Medicine Market Size by Country
9.3.1 Latin America Covid-19 Treatment Medicine Sales by Country (2017-2028)
9.3.2 Latin America Covid-19 Treatment Medicine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Covid-19 Treatment Medicine Market Size by Type
10.1.1 Middle East and Africa Covid-19 Treatment Medicine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Covid-19 Treatment Medicine Revenue by Type (2017-2028)
10.2 Middle East and Africa Covid-19 Treatment Medicine Market Size by Application
10.2.1 Middle East and Africa Covid-19 Treatment Medicine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Covid-19 Treatment Medicine Revenue by Application (2017-2028)
10.3 Middle East and Africa Covid-19 Treatment Medicine Market Size by Country
10.3.1 Middle East and Africa Covid-19 Treatment Medicine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Covid-19 Treatment Medicine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer (Paxlovid)
11.1.1 Pfizer (Paxlovid) Corporation Information
11.1.2 Pfizer (Paxlovid) Overview
11.1.3 Pfizer (Paxlovid) Covid-19 Treatment Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer (Paxlovid) Covid-19 Treatment Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer (Paxlovid) Recent Developments
11.2 VEKLURY (Remdesivir)
11.2.1 VEKLURY (Remdesivir) Corporation Information
11.2.2 VEKLURY (Remdesivir) Overview
11.2.3 VEKLURY (Remdesivir) Covid-19 Treatment Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 VEKLURY (Remdesivir) Covid-19 Treatment Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 VEKLURY (Remdesivir) Recent Developments
11.3 Lagevrio
11.3.1 Lagevrio Corporation Information
11.3.2 Lagevrio Overview
11.3.3 Lagevrio Covid-19 Treatment Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Lagevrio Covid-19 Treatment Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Lagevrio Recent Developments
11.4 GSK (Sotrovimab)
11.4.1 GSK (Sotrovimab) Corporation Information
11.4.2 GSK (Sotrovimab) Overview
11.4.3 GSK (Sotrovimab) Covid-19 Treatment Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 GSK (Sotrovimab) Covid-19 Treatment Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GSK (Sotrovimab) Recent Developments
11.5 Regeneron (Ronapreve)
11.5.1 Regeneron (Ronapreve) Corporation Information
11.5.2 Regeneron (Ronapreve) Overview
11.5.3 Regeneron (Ronapreve) Covid-19 Treatment Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Regeneron (Ronapreve) Covid-19 Treatment Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Regeneron (Ronapreve) Recent Developments
11.6 Yiling Pharmaceutical
11.6.1 Yiling Pharmaceutical Corporation Information
11.6.2 Yiling Pharmaceutical Overview
11.6.3 Yiling Pharmaceutical Covid-19 Treatment Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Yiling Pharmaceutical Covid-19 Treatment Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Yiling Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Covid-19 Treatment Medicine Industry Chain Analysis
12.2 Covid-19 Treatment Medicine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Covid-19 Treatment Medicine Production Mode & Process
12.4 Covid-19 Treatment Medicine Sales and Marketing
12.4.1 Covid-19 Treatment Medicine Sales Channels
12.4.2 Covid-19 Treatment Medicine Distributors
12.5 Covid-19 Treatment Medicine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Covid-19 Treatment Medicine Industry Trends
13.2 Covid-19 Treatment Medicine Market Drivers
13.3 Covid-19 Treatment Medicine Market Challenges
13.4 Covid-19 Treatment Medicine Market Restraints
14 Key Findings in The Global Covid-19 Treatment Medicine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer